NasdaqGS - Delayed Quote USD
Syros Pharmaceuticals, Inc. (SYRS)
At close: 4:00 PM EST
After hours: 4:37 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AKKARAJU SRINIVAS Director | Conversion of Exercise of derivative security | Sep 16, 2024 | 9,333 |
| CHEE CONLEY Chief Executive Officer | Conversion of Exercise of derivative security | Oct 31, 2024 | 130,797 |
| FANUCCI MARSHA H Director | Stock Award(Grant) | Jun 5, 2024 | 16,000 |
| HAAS JASON Chief Financial Officer | Conversion of Exercise of derivative security | Oct 31, 2024 | 137,803 |
| QUIRK GERALD E. Officer | Conversion of Exercise of derivative security | Sep 30, 2024 | 46,657 |
| ROTH DAVID A M.D. Officer | Conversion of Exercise of derivative security | Oct 31, 2024 | 12,099 |
| SIMONIAN NANCY A Director | Conversion of Exercise of derivative security | Oct 31, 2024 | 175,783 |
| STEPHENS KRISTIN Officer | Conversion of Exercise of derivative security | Oct 31, 2024 | 36,133 |
| WIRTH PETER Director | Stock Award(Grant) | Jun 5, 2024 | 16,000 |
| YOUNG RICHARD A Director | Conversion of Exercise of derivative security | Sep 16, 2024 | 10,667 |
Related Tickers
TNGX Tango Therapeutics, Inc.
2.8300
-12.65%
AVTE Aerovate Therapeutics, Inc.
2.7400
-0.72%
EQ Equillium, Inc.
0.7655
+1.88%
XLO Xilio Therapeutics, Inc.
1.0400
-19.38%
EPIX ESSA Pharma Inc.
1.7700
+3.51%
MCRB Seres Therapeutics, Inc.
0.7152
-5.30%
ATRA Atara Biotherapeutics, Inc.
10.10
+0.95%
LYEL Lyell Immunopharma, Inc.
1.2200
-17.57%
SANA Sana Biotechnology, Inc.
3.1000
-9.09%
RAPT RAPT Therapeutics, Inc.
3.1000
+13.97%